Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.
Bicigalupo
A
A
Lamparelli
T
T
Gualandi
F
F
Bregante
S
S
Raiola
A
A
di Grazia
C
C
Dominietto
A
A
Romagnani
C
C
Occhini
D
D
Frassoni
F
F
van Lint
M T
MT
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D007938:Leukemia / Q000453:epidemiology / Q000628:therapy*; D015993:Life Tables; D008875:Middle Aged; D012008:Recurrence; D012306:Risk; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine